Predictive and prognostic implications of KRAS genotype in patients with metastatic colorectal cancer (MCRC) treated with FIr-B/FOx association. Effect of a gene expression-based tissue of origin test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback